IRCT20220516054875N1
Not yet recruiting
Phase 1
Exploring the pharmacist's intervention for precluding the factors effecting medication adherence in Chronic Obstructive Pulmonary Diseases (COPD) following GOLD (Global Initiative for Chronic Obstructive Lungs diseases) guidelines in Pakistan
Quaid-i-Azam University , Islamabad0 sites150 target enrollmentTBD
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD).
- Sponsor
- Quaid-i-Azam University , Islamabad
- Enrollment
- 150
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients only attend the outpatient COPD wards, confirmed diagnosis of COPD by the hospital consultant for at least 1 year
- •Newly diagnosed patients with a forced expiratory volume in 1 s (FEV1\) of 30–80% of the predicted normal value
- •Patients that hospital consultant agree that the patient is suitable for entering the trial
Exclusion Criteria
- •Moderate to severe learning difficulties
- •Mobility problems, confusion, disorientation or terminal illness
- •Congestive heart failure or if they are attending a pulmonary rehabilitation programs consulting a pulmonary nurse or clinical pharmacist in the last 6 months
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A pharmacist-led medicines review intervention in community-dwelling Maori older adults– a feasibility study.ACTRN12619001070123School of Pharmacy, University of Auckland17
Completed
Not Applicable
Development of intervention tool and its effect on health care of patients with dyslipidemia by community pharmacistsDyslipidemiaJPRN-UMIN000044945Showa University40
Not yet recruiting
Not Applicable
A combined, tailored pharmacist intervention with dose optimization of phosphate binding drugs to improve phosphate control in patients on dialysis.NL-OMON24286Franciscus Gasthuis and Vlietland45
Completed
Not Applicable
Influence investigation by the pharmacist follow after the medicatioDiabetesJPRN-UMIN000042922others Chiba Pharmaceutical Association37
Completed
Not Applicable
Evaluation of Pharmacist Intervention for improving Adherence of Immunosuppressive Regimen in Kidney Transplant RecipientsKidney Transplant.Kidney transplant statusZ94.0IRCT20150706023084N9Islamic Azad University, Pharmaceutical Sciences Branch50